A 3D Bioprinted PDA/CSCA/PAM Hybrid Hydrogel Patch for Myocardial Infarction Healing
Biotechnology Journal · 2025
DOI: 10.1002/biot.70169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Yiran Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Hospital of Dalian University of Technology, Dalian R&D Center for Stem Cell and Tissue Engineering, Dalian University of Technology, Dalian, …. Hauptthemen laut MEDLINE: Myocardial Infarction, Hydrogels, Bioprinting. Die Arbeit nennt 80 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Open Fund of Key Laboratory of Biotechnology and Bioresources Utilization (Dalian Minzu University), Ministry of Education of China, Fok Ying Tung Education Foundation.
Abstract (Originalsprache)
Cardiovascular diseases are a leading global cause of mortality, with cardiac patches (CPs) emerging as a novel surgical treatment. This study used a combined decellularization method with sodium dodecyl sulfate (SDS), Triton X‐100, and DNase to process porcine myocardial tissue (PMT), yielding decellularized extracellular matrix (dECM). Quantitative analysis revealed that the dECM contained collagen, DNA, and glycosaminoglycans (GAGs) at concentrations of 2.63 ± 0.37 µg/mg, 4.27 ± 0.79 ng/mg, and 15.94 ± 0.60 µg/mg. Additionally, a conductive hydrogel patch (PDA/CSCA/PAM) with a uniform porous structure and excellent mechanical properties was developed. Its adhesive strengths on glass, stainless steel, and PMT were 50.71 ± 2.88 kPa, 34.19 ± 3.63 kPa, and 54.71 ± 3.24 kPa, respectively. Bacterial inhibition rates reached 103.26 ± 3.52% (Day 1) and 99.26 ± 5.35% (Day 3), indicating significant antimicrobial efficacy. The patch met myocardial tissue engineering standards for swelling ratio, hydrophilicity (contact angle
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Hospital of Dalian University of Technology, Dalian R&D Center for Stem Cell and Tissue Engineering, Dalian University of Technology, Dalian, China.
- Institute For Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Broadway, Australia.
- Department of Hand and Foot Microsurgery, Dalian Municipal Central Hospital Affiliated to Dalian University of Technology, Dalian, China.
- College of Life Science, Dalian Minzu University, Dalian, China.
- Key Laboratory of Biotechnology and Bioresources Utilization of Ministry of Education, Dalian Minzu University, Dalian, China.
Förderung
- National Natural Science Foundation of China
- Open Fund of Key Laboratory of Biotechnology and Bioresources Utilization (Dalian Minzu University), Ministry of Education of China
- Fok Ying Tung Education Foundation
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Tang, Y., Xu, J., Liu, W., Zhu, J., Fang, H., He, L., Liu, H., Cheng, Y. Y., Li, X., Sun, H., Zhang, W., & Song, K. (2025). A 3D Bioprinted PDA/CSCA/PAM Hybrid Hydrogel Patch for Myocardial Infarction Healing. Biotechnology Journal. https://doi.org/10.1002/biot.70169
Vancouver
Tang Y, Xu J, Liu W, Zhu J, Fang H, He L, et al. A 3D Bioprinted PDA/CSCA/PAM Hybrid Hydrogel Patch for Myocardial Infarction Healing. Biotechnology Journal. 2025. doi:10.1002/biot.70169
BibTeX
@article{Tang2025,
author = {Tang, Yiran and Xu, Jie and Liu, Wang and Zhu, Jingjing and Fang, Huan and He, Langyu and Liu, Hongxi and Cheng, Yuen Yee and Li, Xiangqin and Sun, Huanwei and Zhang, Wei and Song, Kedong},
title = {A 3D Bioprinted PDA/CSCA/PAM Hybrid Hydrogel Patch for Myocardial Infarction Healing},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70169}
}
EUVIMED